Trevor Riley

834 total citations
8 papers, 711 citations indexed

About

Trevor Riley is a scholar working on Pulmonary and Respiratory Medicine, Biomaterials and Organic Chemistry. According to data from OpenAlex, Trevor Riley has authored 8 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Biomaterials and 3 papers in Organic Chemistry. Recurrent topics in Trevor Riley's work include Nanoparticle-Based Drug Delivery (4 papers), Advanced Polymer Synthesis and Characterization (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Trevor Riley is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Advanced Polymer Synthesis and Characterization (3 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Trevor Riley collaborates with scholars based in United Kingdom, United States and Sweden. Trevor Riley's co-authors include Snow Stolnik, Martin C. Garnett, Lisbeth Illum, Caiqiao Xiong, Paul Gellert, C. R. Heald, R. J. Barlow, S.S. Davis, S.S. Davis and Thirumala Govender and has published in prestigious journals such as Langmuir, International Journal of Pharmaceutics and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Trevor Riley

8 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Trevor Riley United Kingdom	6	393	248	158	148	123	8	711
C. R. Heald United Kingdom	9	533 1.4×	308 1.2×	189 1.2×	162 1.1×	35 0.3×	10	811
Samia Daoud-Mahammed France	10	329 0.8×	154 0.6×	203 1.3×	234 1.6×	24 0.2×	10	691
Fanny De Jaeghere Switzerland	7	353 0.9×	64 0.3×	157 1.0×	293 2.0×	62 0.5×	8	626
Stephanie Hornig Germany	11	389 1.0×	352 1.4×	200 1.3×	115 0.8×	17 0.1×	16	965
Bruno H. Vilsinski Brazil	17	216 0.5×	94 0.4×	265 1.7×	65 0.4×	169 1.4×	35	695
Samer R. Abulateefeh Jordan	15	254 0.6×	119 0.5×	211 1.3×	101 0.7×	22 0.2×	27	703
Antje Vollrath Germany	18	362 0.9×	401 1.6×	251 1.6×	103 0.7×	21 0.2×	40	1.0k
Anne Brindley United Kingdom	8	149 0.4×	67 0.3×	78 0.5×	92 0.6×	105 0.9×	9	379
Fukashi Kohori Japan	13	543 1.4×	395 1.6×	313 2.0×	73 0.5×	19 0.2×	23	1.1k
Takayuki Yoshida Japan	13	191 0.5×	141 0.6×	145 0.9×	151 1.0×	15 0.1×	29	628

Countries citing papers authored by Trevor Riley

Since Specialization

Citations

This map shows the geographic impact of Trevor Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trevor Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trevor Riley more than expected).

Fields of papers citing papers by Trevor Riley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trevor Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trevor Riley. The network helps show where Trevor Riley may publish in the future.

Co-authorship network of co-authors of Trevor Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Trevor Riley. A scholar is included among the top collaborators of Trevor Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trevor Riley. Trevor Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Norris, Virginia, Claire Ambery, & Trevor Riley. (2014). Pharmacokinetics and pharmacodynamics of GSK961081, a novel inhaled muscarinic antagonist β₂‐agonist, and fluticasone propionate administered alone, concurrently and as a combination blend formulation in healthy volunteers. Clinical Pharmacology in Drug Development. 3(4). 305–313. 5 indexed citations

Riley, Trevor, David Christopher, Andrea Casazza, et al.. (2012). Challenges with Developing In Vitro Dissolution Tests for Orally Inhaled Products (OIPs). AAPS PharmSciTech. 13(3). 978–989. 78 indexed citations

Riley, Trevor, C. R. Heald, Snow Stolnik, et al.. (2003). Core−Shell Structure of PLA−PEG Nanoparticles Used for Drug Delivery. Langmuir. 19(20). 8428–8435. 126 indexed citations

Riley, Trevor, Snow Stolnik, Martin C. Garnett, et al.. (2002). Use of Viscoelastic Measurements for Investigating Interparticle Interactions in Dispersions of Micellar-like Poly(lactic acid)−Poly(ethylene glycol) Nanoparticles. Langmuir. 18(20). 7663–7668. 6 indexed citations

Snowden, Martin J., et al.. (2001). Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system. International Journal of Pharmaceutics. 221(1-2). 165–174. 45 indexed citations

Riley, Trevor, Snow Stolnik, C. R. Heald, et al.. (2001). Physicochemical Evaluation of Nanoparticles Assembled from Poly(lactic acid)−Poly(ethylene glycol) (PLA−PEG) Block Copolymers as Drug Delivery Vehicles. Langmuir. 17(11). 3168–3174. 257 indexed citations

Roberge, Raymond J., et al.. (2000). Diarrhea-associated over-anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine.. PubMed. 42(6). 351–3. 3 indexed citations

Riley, Trevor, Thirumala Govender, Snow Stolnik, et al.. (1999). Colloidal stability and drug incorporation aspects of micellar-like PLA–PEG nanoparticles. Colloids and Surfaces B Biointerfaces. 16(1-4). 147–159. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact